Cogent Biosciences (COGT) Price/FCF Ratio: History & Chart

Cogent Biosciences, Inc.(COGT)

Biotechnology · Waltham, MA

$30.14-0.73 (-2.38%)

Delayed quote: Oct 6, 2026, 10:25 AM EDT

About Cogent Biosciences, Inc.

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.

Waltham, MA

258 employees

www.cogentbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Andrew R. Robbins

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Cogent Biosciences, Inc. (COGT)	$5.15B	N/A	N/A	N/A	N/A
Merit Medical Systems, Inc. (MMSI)vs ›	$5.09B	25.02	26.02	39.55	43.37
Scholar Rock Holding Corporation (SRRK)vs ›	$5.05B	N/A	35.18	35.18	35.18
CRISPR Therapeutics AG (CRSP)vs ›	$5.28B	N/A	13.18	68.65	68.65
Doximity, Inc. (DOCS)vs ›	$5.33B	17.81	21.47	35.28	47.18
Erasca, Inc. (ERAS)vs ›	$4.92B	N/A	N/A	N/A	N/A
Mirum Pharmaceuticals, Inc. (MIRM)vs ›	$4.83B	N/A	99.02	99.02	99.02
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.54B	N/A	N/A	N/A	N/A
BillionToOne, Inc. (BLLN)vs ›	$4.75B	143.22	194.41	194.41	194.41
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.72B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Cogent Biosciences, Inc. (COGT)

$5.15B

N/A

Merit Medical Systems, Inc. (MMSI)vs ›

$5.09B

25.02

26.02

39.55